NCT03764384View on ClinicalTrials.gov

Validation Of Tidal/End -Tidal CO2 in ALS

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

June 4, 2021

Study Completion Date

June 4, 2021

Conditions
Motor Neuron DiseaseAmyotrophic Lateral Sclerosis
Trial Locations (1)

CB23 3RE

Royal Papworth NHS Foundation Trust, Papworth Everard

Sponsors

Collaborators (1)

Innovate UK
All Listed Sponsors
collaborator

Motor Neurone Disease Association

UNKNOWN

collaborator

Innovate UK

OTHER_GOV

collaborator

DOCATEF

UNKNOWN

collaborator

TidalSense

INDUSTRY

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT03764384 - Validation Of Tidal/End -Tidal CO2 in ALS | Biotech Hunter | Biotech Hunter